QD: News Every Day--H1N1 'emergency' and vaccine shortage. ACP Internist's daily digest of news and events continues with H1N1 updates, and physicians speaking out about health care reform. ... H1N1 influenza. The weekend's health news had one theme:
1) Why does CDC utilize outpatient, sick controls in their estimates of vaccine efficacy? ... It appears this case-control method is standard in the influenza vaccine literature.
Autism does present in early life and vaccines are given in early life, so a reasonable parent with a child who develops autism might suspect that the vaccine caused the autism, ... We should carefully weigh both the value of controlling vaccine
An expansion of approval for the Zostavax vaccine, for the prevention of shingles in individuals 50 to 59 years of age. ... The vaccine was already approved for use in individuals 60 years of age and older.
This has been a wrenching issue for many families who are convinced that measles (MMR vaccine) or other vaccines caused their children to develop this serious illness. ... While every vaccine, including measles, has potential side-effects, these are rare
A vaccine (Trumenba) to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroup B in patients 10 through 25 years. ... Previously, FDA-approved meningococcal vaccines only covered serogroups A, C, Y, and W.
annually, causing hundreds of deaths. In 1963 the measles vaccine was introduced, leading to an immediate decrease of measles cases in this country. ... These numbers have much to teach about how vaccines work and how they don't work.
Was this year's flu vaccine good enough? Let me tell you about two patients. ... This is on par with previous data on flu vaccines. Some studies have shown much less benefit in older adults.
Vaccines for the 2010-2011 influenza season in the United States, which contain three strains: A/California/7/09 (H1N1)-like virus (pandemic [H1N1] 2009 influenza virus), A/Perth /16/2009
QD: News Every Day--Pilot study finds that vaccines benefit metastatic breast, ovarian cancers. ... As the National Cancer Institute explains, cancer vaccines work by activating B cells and killer T cells against cancer.